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Introduction
It is well known that obesity is a serious health problem that poses a 
significant challenge to both individual and public health. The latest 
data from the World Health Organization show that worldwide there 
are some 1.6 billion adults who are overweight, with a body mass 
index (BMI) above 25 kg/m2. Of these, at least 400 million adults are 
obese, with a BMI above 30 kg/m2. The latest prevalence figures for 
obesity within the European region confirm that in most countries, 
the number of obese women surpasses the number of obese men, 
sometimes as much as 2 to 1.
However, what is not generally recognised is the fact that obesity 
also has a greater impact on health outcomes for women than for 
men. This impact is seen in the physical, reproductive, psychological 
and social well-being of women compared to men. 
One example is the well-known association between obesity and 
type 2 diabetes. What is rarely reported is the difference between 
men and women in the relationship between obesity and type 2 
diabetes. The relative risk of developing type 2 diabetes for a woman 
with a BMI of 30 kg/m2 is 28-fold compared to that of a woman with 
a BMI < 22 kg/m2.1 In contrast, the difference in risk between men 
with similar BMI values is sevenfold.2
Adolescence and young adulthood
Obesity can have an adverse impact on health at each stage of 
a woman’s life. In young women, obesity has an impact on their 
psychosocial health and, as they grow older, on their reproductive 
health.
The social and economic consequences of obesity were demonstrated 
in a study of a representative sample of 10 039 American adolescent 
and young adult men and women (aged 16 to 24 years). On follow-up 
seven years after the initial survey, women who had been overweight 
(defined as BMI above the 95th percentile for age and sex) at 
baseline had indices of socio-economic status that were worse than 
those of women of normal weight. The survey showed that these 
women were more likely to have had fewer years of education, to 
be living in poverty and to have lower household incomes, and that 
they were less likely to be married, independent of baseline socio-
economic status and aptitude test scores.3 Furthermore, for each 
of these indices, the difference between overweight subjects and 
subjects of normal weight was more pronounced in women than in 
men (see Figure 1).
As women enter their childbearing years, obesity impacts on 
reproductive health. Obesity is associated with increased rates 
of infertility and risk for polycystic ovary syndrome (PCOS). The 
relationship between adolescent BMI and menstrual irregularity and 
ovulatory infertility was investigated in the Nurses’ Health Study. 
The association between menstrual cycle irregularity from age 18 
to 22 and BMI at age 18 was examined in the baseline cohort of 
over 116 000 women. Ovulatory failure was assessed in a case-
control study within the main study: the cases were 2 527 married 
nulliparous nurses who were unable to become pregnant for at least 
one year because of ovulatory disorder (assessed by questionnaire 
and in some cases by review of medical records); controls were 
46 718 married parous nurses with no history of infertility. As shown 
in Figure 2, as BMI at age 18 exceeded 25 kg/m2, the prevalence 
of menstrual cycle irregularity increased and the risk of ovulatory 
failure increased.4 
In women with PCOS and in women without PCOS, increased BMI 
was associated with an increased relative risk of infertility.4
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Obesity in pregnancy
Obesity poses a number of serious risks during pregnancy. In early 
pregnancy, medical complications in obese women include increased 
twinning and a higher rate of miscarriage; in addition, ultrasound can 
be difficult. During pregnancy, higher rates of pregnancy-induced 
hypertension and pre-eclampsia, higher rates of gestational diabetes 
and higher rates of venous thromboembolism are all associated with 
obesity. During delivery, obese women are likely to have higher rates 
of dystocia and, therefore, of assisted delivery and vaginal tears. 
There are also associated technical difficulties, with higher rates of 
infection, bleeding and thrombosis compared to non-obese women 
who have assisted deliveries and Caesarean sections. Anaesthesia 
poses a further challenge in obese mothers.5
After delivery, obese women are at increased risk for postpartum 
haemorrhage and infection, and also at increased risk for venous 
thromboembolism. Obesity in pregnancy also poses serious health 
risks for the fetus. Impaired glucose tolerance (IGT) in pregnant 
women can lead to macrosomia. There is also a risk of birth injury, 
and there is an increased risk of congenital abnormalities, foetal 
distress, perinatal morbidity and mortality.5
In 2003, the US Behavioral Risk Factor Surveillance System assessed 
the rate of obesity in women aged 18 to 44 years at 19.6%.6 This is 
likely to under-report the true rate of obesity, as the data come from 
a telephone questionnaire survey, in which respondents are likely to 
over-estimate their height and under-estimate their weight. Obesity 
is now such a widespread problem that the Institute of Medicine 
in the USA7 has made recommendations for weight gain during 
pregnancy for normal-weight, overweight and obese women (see 
Table I). There is no comparable uniform recommendation across the 
European Union for weight gain in pregnancy.
Intergenerational programming
One emerging issue of great concern in reproductive health and 
obesity is the intergenerational implications of childbearing in obese 
women. There is evidence from epidemiologic and animal studies 
supporting the nutritional programming of obesity and other chronic 
diseases in foetal and early life. Clearly, since fetuses of both genders 
are subject to the intrauterine environment, obesity in women in this 
context can impact both genders.
Figure 3 shows a paradigm for intergenerational programming, 
highlighting how the mother’s nutritional status can influence 
the fetus as well as the development of obesity in adult life.8 
Figure I: Young adulthood 
Social and economic consequences of obesity  
Effect of weight status at age 16-24 over 7 years of follow-up Non Overweight Overweight
Adapted from Gortmaker SL< Must A, Perrin JM, et al.NEJM 1993. 329:1008-1012
Adapted from Rich-Edwards JW, Goldman MB, Willett WC, et al.Am J Obstet Gynecol 1994;171:171-7
Figure 2: Relative risk of menstrual cycle irregularity and ovulatory failure at 
different Body mass indices (BMI) 
Table I: Institute of Medicine recommendations for weight gain during pregnancy
BMI (kg/m2)   Recommended gain
< 18.5 12.5 – 18 kg
18.5 – 24.9 11.5 – 16 kg
25 – 29.9 7 – 11.5 kg
> 30 7 kg
Abbreviation:  BMI:  body mass index 
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The implication is that both under-nutrition and over-nutrition – 
associated with gestational diabetes, maternal obesity and excessive 
weight gain – increase the infant’s risk of later excessive body fat 
and the subsequent risk in adulthood of developing obesity, diabetes, 
hypertension and cardiovascular disease (CVD).
Gestational diabetes mellitus occurs in around 4% of all pregnancies. 
In overweight women, the prevalence increases significantly to 17%. 
Risk estimates of type 2 diabetes after gestational diabetes vary from 
17 to 63% over 5 to 16 years, depending on the ethnic background 
of the study population and the sensitivity of the detection method 
used for both type 2 diabetes and gestational diabetes.9–11
The emerging evidence from animal studies and human observational 
studies indicates a need for concern about maternal-foetal interaction 
and also the interaction between mother and infant in early life. This 
appears to be a critical period of programming that can lead to the 
development of increased risk for chronic disease. In a study designed 
to assess the hypothesis that a long-term postnatal development 
may be modified by metabolic experiences in utero, children of 
women with pregestational diabetes and gestational diabetes were 
reviewed annually to measure the prevalence of impaired glucose 
tolerance (IGT).12 IGT was 1.2% at < 5 years, increasing to 5.4% at 
5 to 9 years, and by the age of 10 to 16 years, 19.3% of the children 
of diabetic mothers had IGT, compared to around 2% in a control 
group. In other words, the children had 10 times the risk of IGT at a 
preadolescent age.
A relationship has also been observed between prevalence of obesity 
in children and their mothers’ metabolic status. Children whose 
mothers had diabetes during pregnancy had a higher prevalence 
of obesity than children whose mothers had IGT (prediabetes) or 
were non-diabetic during pregnancy. At 15 to 19 years, 58% of 
the children of diabetics weighed 140% or more of their desirable 
weight compared to 17% of the children of non-diabetics and 25% 
of the children of women with prediabetes.13 The children of diabetic 
mothers were significantly more obese than those of non-diabetic 
mothers, regardless of maternal BMI. For the children of non-diabetic 
or prediabetic mothers, the relationship was also evident when the 
data were analysed according to the BMI of the mother; for example, 
in the 15 to 19 age group, the prevalence of obesity ranged from 
19 to 54% according to the BMI of the mother, with the higher BMIs 
being associated with higher rates of obesity in the children.
It is becoming apparent, therefore, that a woman’s nutritional and 
metabolic status during pregnancy can programme her daughter or 
son, and in the case of the daughter when she reaches childbearing 
age, she can in turn impose an effect on the next generation. 
Therefore, obesity in pregnancy may affect several generations to 
come and should therefore be avoided.
Mature and ageing women
As women age, one sees the emergence of obesity-related chronic 
diseases, such as type 2 diabetes, hypertension and CVD.14 There is 
also increased risk for several of the major cancers. 
CVD now ranks as the world’s top cause of death, causing one-third 
of all deaths globally.15 It is also the largest single cause of death 
among women worldwide. In Western countries, more women than 
men die every year of CVD. However, across all cultures and settings, 
men outnumber women in the ratio of three or four to one regarding 
premature (that is before 75 years of age) mortality from coronary 
heart disease.16 Studies have identified a number of factors that may 
protect women against CVD, with the greatest emphasis on 
- higher high-density lipoprotein (HDL) cholesterol
- greater increase in HDL cholesterol in unfavourable dietary 
circumstances, such as when there is more than 30 to 35% 
total fat intake in the diet 
- pear-shaped rather than apple-shaped obesity
- better lifestyle
- lesser sympathetic response to stress
- lower blood viscosity, and
- more favourable values for most classical and novel CVD risk 
factors
However, ageing gradually erodes the female advantage. 
Epidemiological studies have shown that the prevalence and 
incidence of CVD among both men and women increase with age,17 
and that the gender difference narrows at older ages. An increase 
in risk-factor levels is associated with the age-related increase in 
CVD in both sexes, but this increase is larger in women.18 Difference 
in serum total cholesterol level, blood pressure, BMI and diabetes 
prevalence have been shown to explain about 50 to 60% of the age-
related increase in coronary heart disease risk in women, compared 
to only about one-third of the increase in men.18
Recent data from the Renfrew-Paisley study, which recruited 15 406 
individuals in Scotland between 1972 and 1976, serve to emphasise 
the importance of obesity as a CVD risk factor in women.19 In 
this analysis, mortality and other outcomes after 20 years were 
calculated according to baseline BMI. While being overweight did 
not increase the relative risks for all-cause mortality, cardiovascular 
mortality or coronary disease, all of these were very clearly increased 
in obese individuals (see Figure 4). In terms of absolute rates of 
CVD, the Renfrew-Paisley study showed that after adjusting for age, 
forced expiratory volume in 1 second, smoking and social class, 
compared to women of normal weight (BMI 18.5 – 24.9 kg/m2), for 
every 100 obese women followed for 20 years there were seven 
additional cases of fatal cardiovascular hospitalisations attributable 
to obesity. The equivalent numbers among men were similar: nine 
additional cases of fatal CVD and thirty-six additional cardiovascular 
hospitalisations attributable to obesity. This study therefore also 
emphasises the magnitude of the health threat posed by obesity.
The increased risk for cancer associated with obesity was illustrated 
in the American Cancer Society study, which followed over 900 000 
individuals between 1982 and 1998. Increased body weight was 
associated with increased death rates for all cancers combined, 
and for cancers at multiple specific sites. Cancer in women showed 
significant trends of increasing risk with higher BMI for death from 
cancers of the breast, uterus, cervix and ovary.20
Of concern in the elderly is the risk that obesity imposes for impaired 
cognitive function and Alzheimer’s disease, and the negative 
implications that obesity has in terms of life expectancy.
Adapted from Martorell R, Stein AD, Schroeder DG.  J Nutr 131:847S-880S, 2001
Figure 3: Paradigm for intergenerational programming
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A population-based study of 959 men and women aged 69 to 78 
years found a strong association between the metabolic syndrome 
(defined according to National Cholesterol Education Program criteria) 
and the risk for Alzheimer’s disease in women (see Figure 5). The 
prevalence of probable or possible Alzheimer’s disease was 8.3% in 
women with the metabolic syndrome and 1.9% in women without 
the metabolic syndrome. The association was not demonstrated 
in men, in whom the prevalence was 3.8 and 3.9% respectively.21 
However, the sample included few cases of Alzheimer’s disease (45 
overall) and it also had a smaller sample of men (337 compared to 
622 women) and, therefore, the validity of the data regarding men is 
not as strong as that regarding women.
There is emerging evidence that obesity is also an independent risk 
factor for cognitive dysfunction and Alzheimer’s disease. Cross-
sectional and longitudinal studies have demonstrated an increased 
risk for dementia and Alzheimer’s disease in obese individuals. In one 
study of 1 449 individuals, obesity (BMI > 30 kg/m2) at midlife was 
associated with increased risk of dementia and Alzheimer’s disease 
in later life, after adjusting for socio-demographic variables.22 Midlife 
obesity, high total cholesterol and high systolic blood pressure were 
all significant risk factors for dementia, and had additive effects. 
In another study, 392 adults aged 70 without dementia were followed 
up for 18 years.23 The findings suggested that overweight at age 
70 is a risk factor for dementia, particularly Alzheimer’s disease, in 
women. Dementia risk was associated with a BMI ≥ 25 kg/m2. BMI 
was, on average, 3.6 higher among those who developed Alzheimer’s 
disease than those who did not. A similar association was not found 
in men. In addition, at least one longitudinal study has demonstrated 
that overweight and obesity are associated with abnormalities in 
areas of the brain that are associated with Alzheimer’s disease, 
with temporal lobe brain atrophy being observed on computerised 
tomography scans.24
Impact on life expectancy 
Obesity and overweight in adulthood have been reported to be 
associated with important reductions in life expectancy. Data from 
the longitudinal Framingham Heart Study were analysed to assess 
the implications of obesity (as measured by BMI) at age 40 on life 
expectancy. The analysis showed that in 40-year-old non-smokers 
(without previously diagnosed CVD) obesity was associated with 
7.1 years of life lost in women and 5.8 years of life lost in men, 
compared to people of normal weight at age 40.25 The difference 
between men and women was not statistically significant, but the 
trend to increased effect for women was of interest. With the double 
burden of obesity and smoking, obese female smokers lost 13.3 
years and obese male smokers lost 13.7 years compared to non-
smokers of normal weight.26
Summary
Obesity has negative consequences for women’s health throughout 
the life cycle, with important psychosocial, economic and biologic 
implications. In addition, obesity in women has the potential of 
having an intergenerational impact if overweight and obese mothers 
transmit risk for chronic disease during their pregnancies.
References
1. Colditz GA, Willet WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. 
Ann Intern Med. 1995;122:481–6.
2. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willet WC. Obesity, fat distribution and weight gain as risk factors for 
clinical diabetes in men. Diabetes Care 1994;17:961–9.
3. Gortmaker SL, Must A, Perrin JM, Sobol AM, Dietz WH. Social and economic consequences of overweight in 
adolescence and young adulthood. New Engl J Med. 1993;329:1008–12.
4. Rich-Edwards JW, Goldman MB, Willett WC, et al. Adolescent body mass index and infertility caused by ovulatory 
disorder. Am J Obstet Gynecol. 1994;171:171–7.
5. WHO. Maternal anthropometry for prediction of pregnancy outcomes: Memorandum from a USAID/WHO/PAHO/
Mother-Care meeting. WHO Bull 1991;69:523–32.
6. Vilsack TJ, Pederson SJ, Hansen MM. Annual Report: Survey Results from 2003, Iowa.
 http://www.idph.state.ia.us/brfss/common/pdf/2003BRFSSannual.pdf
7. Institute of Medicine, Subcommittee on Nutritional Status and Weight Gain during Pregnancy. Nutrition during 
pregnancy. Part I: Weight gain, Part II: Nutrient supplements. Washington, DC: National Academy Press; 1990.
8. Martorell R, Stein AD, Schroeder DG. Early nutrition and later adiposity. J Nutr. 2001;131:874S–880S.
9. Linne Y. Effects of obesity on women’s reproduction and complications during pregnancy. Obes Rev. 
2004;5:137–43.
10. Hanna FW, Peters JR. Screening for gestational diabetes: Past, present and future. Diabet Med. 2002;19:351–8.
11. O’Sullivan JB. Diabetes mellitus after GDM. Diabetes. 1991;40(Suppl 2):131–5.
12. Silverman BL, Metzger BE, Cho NH, Loeb CA. Impaired glucose tolerance in adolescent offspring of diabetic mothers. 
Relationship to fetal hyperinsulinism. Diabetes Care 1995;18:611–17.
13. Pettit DJ, Baird HR, Aleck KA, Bennett PH, Knowler WC. Excessive obesity in offspring of Pima Indian women with 
diabetes during pregnancy. N Engl J Med. 1983;308:242–5.
14. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl Med. 1999; 341:427–34.
15. Mackay J, Mensah G, editors. The atlas of heart disease and stroke. Geneva: World Health Organization; 2004.
16. Allender S, Peto V, Scarborough P, Boxer A, Rayner M. Coronary heart disease statistics. London: British Heart 
Foundation; 2006.
17. Bello N, Mosca L. Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis. 2004;46:287–95.
18. Jousilahti P, Variainen E, Tuomilehto J, Pushka P. Sex, age, cardiovascular risk factors, and coronary heart disease. 
Circulation 1999;99:1165–72.
19. Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJ. Long-term cardiovascular consequences of 
obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart 
J. 2006;27:96–106.
20. Vanhanen M, Koivisto K, Moilanen L, et al. Association of metabolic syndrome with Alzheimer disease: A population-
based study. Neurology 2006;67:843–7.
21. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively 
studied cohort of US adults. N Engl J Med. 2003;348:1625–38.
22. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer 
disease. Arch Intern Med. 2003;163:1524–8.
23. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and 
Alzheimer disease. Arch Neurol. 2005;62:1556–60.
24. Gustafson D, Lissner L, Bengtsson C, Bjorkelund C, Skoog I. A 24-year follow-up of body mass index and cerebral 
atrophy. Neurology 2004;63:1876–81.
25. Pardo Silva MC, De Laet C, Nusselder WJ, Mamun AA, Peeters A. Adult obesity and number of years lived with and 
without cardiovascular disease. Obesity (Silver Spring) 2006;14:1264–73.
26. Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: A life-table 
analysis. Ann Intern Med. 2003;138:24–32.
Compared with normal weight (BMI 18.5–24.9 kg/m2). 
Adjusted for age, adjusted FEV1, smoking, social class; 
p values are for trend. Adapted from Murphy et al.
Figure 4: 20-year mortality risk associated with obesity in the Renfrew-Paisley study 
show that compared with normal-weight individuals, (BMI 18.5 – 24.9kg/m2), obesity 
(BMI ³  30kg/m2) was associated with an increased adjusted risk of all-cause mor-
tality, cardiovascular death (CV), coronary heart disease (CHD) and acute myocardial 
infarction (MI) compared with women of normal weight. Being overweight (BMI 
25-30 kg/m2) was not associated with an increased risk
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